Skip to main content

Disorders of Female Orgasm

  • Chapter
  • First Online:
Cancer and Sexual Health

Part of the book series: Current Clinical Urology ((CCU))

  • 1640 Accesses

Abstract

Both cancer and cancer treatments can have ­deleterious effects on women’s ability to attain orgasm. The degree to which sexual functioning at large is impacted depends on a number of medical, psychological, and social factors including severity of the disease, treatment intensity and length, emotional status during cancer diagnosis and management, access to social support, and comorbid psychological problems. In this chapter, we discuss the diagnosis, prevalence, and treatment of female orgasmic disorder (FOD), with an emphasis, where possible, on how they pertain to women with current or past cancer. Orgasm is a fundamental component of sexual response in both men and women, and is affected frequently in humans from the studies of cancer survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision (DSM-IV-TR). Washington: American Psychiatric Association. 2000.

    Google Scholar 

  2. Levin R. Sexual desire and the deconstruction and reconstruction of the human female sexual response model of Masters and Johnson. In: Everaerd W, Laan E, Both S, editors. Sexual appetite, desire and motivation: energetics of the sexual system. Amsterdam: Koninklijke Nederlandse Akademie van Wetenschappen; 2001. p. 63–93.

    Google Scholar 

  3. Masters WH, Johnson VE. Human sexual response. Oxford: Little Brown; 1966.

    Google Scholar 

  4. Levin R. The mechanisms of human female sexual arousal. Annu Rev Sex Res. 1992;3:1–48.

    Google Scholar 

  5. Whipple B, Ogden G, Komisaruk B. Physiological correlates of imagery-induced orgasm in women. Arch Sex Behav. 1992;21:121–33.

    Article  PubMed  CAS  Google Scholar 

  6. Crevenna R, Homann H, Feichtinger M, Oh E, Körner E. Spontaneous orgasm – an epileptic case without structural correlate. Br J Psychiatry. 2000; 176:300.

    Article  PubMed  CAS  Google Scholar 

  7. Polatin P, Douglas DE. Spontaneous orgasm in a case of schizophrenia. Psychoanal Rev. 1953;40:17–26.

    PubMed  CAS  Google Scholar 

  8. Altindag A, Gunes M. A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:895–6.

    PubMed  Google Scholar 

  9. Pae C, Kim T, Lee K, Lee C, Lee C, Paik I, et al. Paroxetine-associated spontaneous sexual stimulation. Int Clin Psychopharmacol. 2005;20:339–41.

    Article  PubMed  Google Scholar 

  10. Yanik M. Spontaneous orgasm started with venlafaxine and continued with citalopram. Can J Psychiatry. 2004;49:786.

    PubMed  Google Scholar 

  11. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown; 1970.

    Google Scholar 

  12. Frank E, Anderson A, Rubinstein D. Frequency of sexual dysfunction in normal couples. N Engl J Med. 1978;299:111–5.

    Article  PubMed  CAS  Google Scholar 

  13. King M, Holt V, Nazareth I. Women’s views of their sexual difficulties: agreement and disagreement with clinical diagnoses. Arch Sex Behav. 2007;36:281–8.

    Article  PubMed  Google Scholar 

  14. Derogatis L, Schmidt C, Fagan P, Wise T. Subtypes of anorgasmia via mathematical taxonomy. Psychosomatics. 1989;30:166–73.

    PubMed  CAS  Google Scholar 

  15. Meston CM. Validation of the female sexual function index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29:39–46.

    Article  PubMed  Google Scholar 

  16. Rosen RT, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther. 1993;19:171–88.

    PubMed  CAS  Google Scholar 

  17. Basson R, Leiblum S, Brotto L, Fourcroy J, Graziottin A, Laan E, et al. Definitions of women’s sexual ­dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynecol. 2003;24:221–9.

    Article  CAS  Google Scholar 

  18. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med. 1997;19:387–91.

    PubMed  CAS  Google Scholar 

  19. Dunn K, Jordan K, Croft P, Assendelft W. Systematic review of sexual problems: epidemiology and methodology. J Sex Marital Ther. 2002;28:399–422.

    Article  PubMed  Google Scholar 

  20. National Cancer Insitute. Sexuality and reproductive issues. Retrieved from http://www.cancer.gov/cancertopics/pdq/supportivecare/sexuality/Patient/page1. 2004. Accessed in July 2009.

  21. Henson HK. Breast cancer and sexuality. Sex Disabil. 2002;20:261–75.

    Article  Google Scholar 

  22. Incrocci L, Gianotten WL. Disease and sexuality. In: Rowland DL, Incrocci L, editors. Handbook of sexual and gender identity disorders. Hoboken: Wiley; 2008. p. 284–324.

    Google Scholar 

  23. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK, editors. SEER cancer statistics review, 1975–2006. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2006/August 2009, based on November 2008 SEER data submission, posted to the SEER web site, Accessed in July 2009.

  24. Andersen BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997;65: 221–9.

    Article  PubMed  CAS  Google Scholar 

  25. Schover LR, Jensen SB. Sexuality and chronic illness: a comprehensive approach. New York: The Guilford Press; 1988.

    Google Scholar 

  26. Alterowitz R, Alterowitz B. Sexual rehabilitation after cancer. In: Tepper MS, Owens AF, editors. Sexual health, vol. 4. Santa Barbara: Praeger Publishers; 2006. p. 269–311.

    Google Scholar 

  27. Brotto L, Heiman J, Goff B, Lentz G, Tamimi H, Van Blaricom A, et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav. 2008;37:317–29.

    Article  PubMed  Google Scholar 

  28. Stilos K, Doyle C, Daines P. Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs. 2008;12:457–63.

    Article  PubMed  Google Scholar 

  29. Lagana L, Classen C, Caldwell R, McGarvey EL, Baum LD, Cheasty E, et al. Sexual difficulties of patients with gynecological cancer. Prof Psychol Res Pr. 2005;36:391–9.

    Article  Google Scholar 

  30. Krychman ML, Amsterdam A, Carter J. Cancer, sexuality and sexual expression. In: Goldstein I, Meston CM, Davis S, Traish A, editors. Women’s sexual function and dysfunction: study, diagnosis and treatment. London: Informa Healthcare; 2005. p. 636–43.

    Google Scholar 

  31. Nunns D, Williamson K, Swaney L, Davy M. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinomas. Int J Gynecol Cancer. 2000;10:233–8.

    Article  PubMed  Google Scholar 

  32. Krychman M, Pereira L, Carter J, Amsterdam A. Sexual oncology: sexual health issues in women with cancer. Oncology. 2006;71:18–25.

    Article  PubMed  Google Scholar 

  33. Corney R, Crowther M, Everett H, Howells A, Shepherd J. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol. 1993;100:73–8.

    Article  PubMed  CAS  Google Scholar 

  34. Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med. 2002;347:1318–25.

    Article  PubMed  Google Scholar 

  35. Jensen P, Groenvold M, Klee M, Thranov I, Petersen M, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function: a longitudinal study. Cancer. 2004;100:97–106.

    Article  PubMed  Google Scholar 

  36. Bruner D, Lanciano R, Keegan M, Corn B, Martin E, Hanks G. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.

    Article  PubMed  CAS  Google Scholar 

  37. Flay L, Matthews J. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995;31:399–404.

    Article  PubMed  CAS  Google Scholar 

  38. Schultz WW, van de Wiel H, Bouma J, Janssens J, Littlewood J. Psychosexual functioning after the treatment of cancer of the vulva: a longitudinal study. Cancer. 1990;66:402–7.

    Article  Google Scholar 

  39. Jensen P, Groenvold M, Klee M, Thranov I, Petersen M, Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2003;56:937–49.

    Article  PubMed  Google Scholar 

  40. Molina J, Barton D, Loprinzi C. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf Int J Med Toxicol Drug Exp. 2005;28: 401–16.

    CAS  Google Scholar 

  41. Young-McCaughan S. Sexual functioning in women with breast cancer after treatment with adjuvant therapy. Cancer Nurs. 1996;19:308–19.

    Article  PubMed  CAS  Google Scholar 

  42. Barni S, Mondin R. Sexual dysfunction in treated breast cancer patients. Ann Oncol. 1997;8:149–53.

    Article  PubMed  CAS  Google Scholar 

  43. Berglund G, Nystedt M, Bolund C, Sjödén P, Rutquist L. Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol. 2001;19:2788–96.

    PubMed  CAS  Google Scholar 

  44. Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol. 1986;54:140–8.

    Article  PubMed  CAS  Google Scholar 

  45. LoPiccolo J, Lobitz WC. The role of masturbation in the treatment of orgasmic dysfunction. Arch Sex Behav. 1972;2:163–71.

    Article  PubMed  CAS  Google Scholar 

  46. Heiman JR, LoPiccolo L, LoPiccolo J. Becoming orgasmic: a sexual growth program for women. Englewood Cliffs: Prentice-Hall; 1976.

    Google Scholar 

  47. Kinsey AC, Pomeroy WD, Martin CE, Gebhard PH. Sexual behavior in the human female. Philadelphia: WB Saunders; 1953.

    Google Scholar 

  48. Laumann EO, Gagnon JH, Michael RT, et al. The social organization of sexuality: sexual practices in the United States. Chicago: University of Chicago Press; 1994.

    Google Scholar 

  49. Barbach LG. Group treatment of preorgasmic women. J Sex Marital Ther. 1974;1:139–45.

    PubMed  CAS  Google Scholar 

  50. Heinrich AG. The effect of group and self-directed behavioral-educational treatment of primary orgasmic dysfunction in females treated without their partners (Doctoral dissertation). Boulder: University of Colorado; 1976.

    Google Scholar 

  51. Delehanty R. Changes in assertiveness and changes in orgasmic response occurring with sexual therapy for preorgasmic women. J Sex Marital Ther. 1982;8:198–208.

    PubMed  CAS  Google Scholar 

  52. McMullen S, Rosen RC. Self-administered masturbation training in the treatment of primary orgasmic dysfunction. J Consult Clin Psychol. 1979;47:912–8.

    Article  PubMed  CAS  Google Scholar 

  53. Fitchen CS, Libman E, Brender W. Methodological issues in the study of sex therapy: effective components in the treatment of secondary orgasmic dysfunction. J Sex Marital Ther. 1983;9:191–202.

    Google Scholar 

  54. Hurlbert DF, Apt C. Coital alignment technique and directed masturbation: a comparative study on female orgasm. J Sex Marital Ther. 1995;21:21–9.

    PubMed  CAS  Google Scholar 

  55. Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol. 2008;26:3943–9.

    Article  PubMed  Google Scholar 

  56. Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys. 2009;73:1501–9.

    Article  PubMed  Google Scholar 

  57. Wolpe J. Psychotherapy by reciprocal inhibition. Palo Alto: Stanford University Press; 1958.

    Google Scholar 

  58. Meston CM, Levin R, Sipski M, Heiman J, Hull E. Women’s orgasm. Annu Rev Sex Res. 2004;15: 173–257.

    PubMed  Google Scholar 

  59. Ott M. Complementary and alternative therapies in cancer symptom management. Cancer Pract. 2002;10:162–6.

    Article  PubMed  Google Scholar 

  60. Marshall C, Kiemle G. Breast reconstruction following cancer: its impact on patients’ and partners’ sexual functioning. Sex Relationship Ther. 2005;20:155–79.

    Article  Google Scholar 

  61. Jankovich R, Miller PR. Response of women with primary orgasmic dysfunction to audiovisual education. J Sex Marital Ther. 1978;4:16–9.

    PubMed  CAS  Google Scholar 

  62. Kegel AH. Sexual functions of the pubococcygeus muscle. West J Surg Obstet Gynecol. 1952;60:521–4.

    PubMed  CAS  Google Scholar 

  63. Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther. 2000;26: 231–40.

    Article  PubMed  CAS  Google Scholar 

  64. Zajecka J, Dunner DL, Gelenberg AJ, Kornstein SG, Rush AJ, Trivedi M, et al. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. J Clin Psychiatry. 2002;63:709–16.

    Article  PubMed  CAS  Google Scholar 

  65. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG. 2001;108:623–8.

    Article  PubMed  CAS  Google Scholar 

  66. Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril. 2006;85:1496–501.

    Article  PubMed  CAS  Google Scholar 

  67. Basson R, Brotto L. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG. 2003; 110:1014–24.

    Article  PubMed  CAS  Google Scholar 

  68. Meston CM, Rellini AH, Telch M. Short-term and long-term effects of Gingko Biloba extract on sexual dysfunction in women. Arch Sex Behav. 2008;37:530–47.

    Article  PubMed  Google Scholar 

  69. Traish A, Feeley R, Guay A. Testosterone therapy in women with gynecological and sexual disorders: a triumph of clinical endocrinology from 1938 to 2008. J Sex Med. 2009;6:334–51.

    Article  PubMed  Google Scholar 

  70. Anastasiadis A, Davis A, Salomon L, Burchardt M, Shabsigh R. Hormonal factors in female sexual dysfunction. Curr Opin Urol. 2002;12:503–7.

    Article  PubMed  Google Scholar 

  71. Hickey M, Saunders C, Stuckey B. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol. 2005;6:687–95.

    Article  PubMed  Google Scholar 

  72. Shufelt C, Braunstein G. Safety of testosterone use in women. Maturitas. 2009;63:63–6.

    Article  PubMed  CAS  Google Scholar 

  73. Warren M, Halpert S. Hormone replacement therapy: controversies, pros and cons. Best Pract Res Clin Endocrinol Metab. 2004;18:317–32.

    Article  PubMed  CAS  Google Scholar 

  74. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and risk of coronary heart disease. N Engl J Med. 2003;349:523–34.

    Article  PubMed  CAS  Google Scholar 

  75. Rossouw J, Prentice R, Manson J, Wu L, Barad D, Barnabei V, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc. 2007;297(13):1465–77.

    Article  CAS  Google Scholar 

  76. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early stage breast cancer. N Engl J Med. 1999;340:1733–9.

    Article  PubMed  CAS  Google Scholar 

  77. Gotay CC, Hara W, Issell BF, Maskarinec G. Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J. 1999;58:94–8.

    PubMed  CAS  Google Scholar 

  78. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18:2505–14.

    PubMed  CAS  Google Scholar 

  79. Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000;27:623–30.

    PubMed  CAS  Google Scholar 

  80. White J. The National Cancer Institute’s perspective and agenda for promoting awareness and research on alternative therapies for cancer. J Altern Complement Med. 2002;8:545–50.

    Article  PubMed  Google Scholar 

  81. Cassileth B. Complementary therapies: overview and state of the art. Cancer Nurs. 1999;22(1):85–90.

    Article  PubMed  CAS  Google Scholar 

  82. Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281(6):537–44.

    Google Scholar 

  83. Stead ML. Sexual dysfunction after treatment for gynaecologic and breast malignancies. Curr Opin Obstet Gynecol 2003;15(1):57–61.

    Google Scholar 

  84. Krychman ML, Stelling CJ, Carter J, Hudis CA. A Case series of androgen use in breast cancer survivors with sexual dysfunction. J Sex Med 2007;4(6):1769–74.

    Google Scholar 

  85. Schover LR. Sexuality and fertility after cancer. Hematology. 2005:523–7.

    Google Scholar 

  86. Ito TY, Trant AS, Polan ML. A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther 2001;27:541–9.

    Google Scholar 

  87. Michelson D, Kociban K, Tamura R et al. Mirtazapine, yohimbine, or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: A randomized, placebo controlled trial. J Psychiatr Res 2002;36:147–152.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Khouri, Y.P., Hughan, C.P., Meston, C.M. (2011). Disorders of Female Orgasm. In: Mulhall, J., Incrocci, L., Goldstein, I., Rosen, R. (eds) Cancer and Sexual Health. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-60761-916-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-916-1_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-915-4

  • Online ISBN: 978-1-60761-916-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics